Ancilia Biosciences, Inc. — Form D
Ancilia Biosciences, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-06. The offering totals $10.1M, of which $10.1M was reported sold. Industry: Other.
Offering
- Filed: 2026-04-06
- Form: D
- Accession: 0001975776-26-000006
- Industry: Other
- Exemptions: 06b
- Total offering: $10.1M
- Amount sold: $10.1M
- Investors: 23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-579209
Issuer
- Name: Ancilia Biosciences, Inc.
- CIK: 0001975776
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3960 BROADWAY, 6TH FLOOR, NEW YORK, NY, 10032
- Phone: 716-474-6710
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Rodolphe Barrangou | Related Person | LONG ISLAND CITY, NY |
| Gurdane Bhutani | Related Person | Claymont, DE |
| Dale Pfost | Related Person | LONG ISLAND CITY, NY |
| Alexandra Sakatos | Related Person | LONG ISLAND CITY, NY |
| Vera Schroeder | Related Person | LONG ISLAND CITY, NY |
| Dale Pfost | Director | LONG ISLAND CITY, NY |
| Rodolphe Barrangou | Director | LONG ISLAND CITY, NY |
| Rodolphe Barrangou | Executive Officer | LONG ISLAND CITY, NY |
| Alexandra Sakatos | Director | LONG ISLAND CITY, NY |
| Alexandra Sakatos | Executive Officer | LONG ISLAND CITY, NY |
Other filings by this issuer (1)
More